Applications of 5-Azacytosine in Industrial Manufacturing

5-Azacytosine is a niche chemical raw material produced for several advanced industrial manufacturing processes, primarily in the pharmaceutical, life sciences, and specialty research sectors. Our manufacturing expertise ensures the required purity, consistency, and traceability for the following downstream applications.

1. Nucleoside Analog Synthesis for Oncology APIs

In pharmaceutical synthesis, 5-Azacytosine serves as a core building block for nucleoside analogs, particularly in the production of antineoplastic active pharmaceutical ingredients such as azacitidine and decitabine. During API manufacturing, this material undergoes condensation and glycosylation steps, ultimately integrating into cytidine analogs with demethylating activity relevant for acute myeloid leukemia and myelodysplastic syndromes. Manufacturers control reaction conditions and employ GMP-compliant workflows for batch consistency.

Industry compliance standards

• ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• EU GMP Annex 1 (sterile manufacturing, where applicable)
• Ph. Eur. monographs for azacitidine/decitabine APIs
• USP <941>, <1121>, raw material source traceability

Typical usage ratio

• 5-Azacytosine forms ~20-35% molar ratio in nucleoside precursor synthesis, adjusted for coupling efficiency and downstream conversion rates.

Downstream process integration

• Material introduced post-deprotection during early chemical synthesis; undergoes glycosylation and sugar attachment steps; isolated prior to subsequent transformations and purification cycles in API manufacture.

Final product types

• Pharmaceutical-grade azacitidine API
• Pharmaceutical-grade decitabine API
• Other custom nucleoside analog intermediates for oncology research

2. Epigenetic Research Reagent Production

Researchers incorporate 5-Azacytosine into specialized kits and chemical libraries designed for DNA methylation inhibition studies. The compound’s unique ring structure facilitates selective incorporation into DNA during cell culture studies, enabling DNA demethylation analysis across multiple biomedical research labs. Manufacturers of research use only (RUO) reagents rely on high-purity lots, validated by HPLC and LC-MS, and often formulate lyophilized or buffered solutions incorporating this active base.

Industry compliance standards

• ISO 9001:2015 for laboratory reagents
• OECD Guidelines: Good Laboratory Practice (GLP) for research material quality
• REACH (EC 1907/2006) substance registration for EU-based distribution
• Labeling compliance with GHS/CLP for chemical safety

Typical usage ratio

• Supplied as 1-10 mM solutions or powder formulations; typical kit concentrations range from 0.1% to 1.0% w/w depending on experimental design and application protocol.

Downstream process integration

• Material dissolved in proprietary buffers; aliquoted into kit vials for direct use in cell culture or PCR workflows; freeze-dried forms for enhanced shelf-life and stability in global shipment.

Final product types

• Epigenetic DNA methylation analysis kits
• Research-grade DNA demethylating reagent vials
• Custom cell culture additives for academic and biotech labs

3. Custom Oligonucleotide and Probe Manufacturing

Oligonucleotide manufacturers incorporate 5-Azacytosine as a modified nucleobase into custom primers and molecular probes for specific molecular biology and gene expression studies. The material provides enhanced selectivity for methylation-sensitive detection and is introduced when synthesizing functionalized oligo chains by automated solid-phase techniques. Purity and batch traceability are critical to avoid sequence errors in synthetic biology applications.

Industry compliance standards

• ISO 13485 for in vitro diagnostic components
• ISO 18385: Minimizing contamination in forensic laboratory processes
• 21 CFR Part 820: Quality System Regulation, where IVDR-related
• Applicable Material Safety Data Sheet (MSDS) documentation

Typical usage ratio

• Nucleobase monomers typically represent 10–30% of total nucleoside content, adjusted to oligo sequence requirements and synthesis protocol design for site-specific incorporation.

Downstream process integration

• Directly integrated at monomer dispensing stage in automated DNA/RNA synthesizers, with coupling run parameters adjusted for base reactivity and protecting group removal; critical for specialty oligonucleotides shipped to end-users.

Final product types

• Custom-synthesized oligonucleotides for research and diagnostics
• Methylation detection probes for PCR and sequencing
• Functionalized gene expression microarray substrates

4. Pharmaceutical Impurity Reference Standard Production

Specialty labs use 5-Azacytosine as a traceable reference standard in the development of impurity profiling assays for regulatory submissions and batch release testing. The compound’s stability supports quantitative HPLC and LC-MS calibration workflows, particularly in quality control of cytidine analog-containing pharmaceutical actives. As a primary standard, it provides batch-to-batch comparability and analytical accuracy for both internal QC and external validation work.

Industry compliance standards

• USP <561>: Articles of Botanical Origin for reference standards
• Ph. Eur. 2.2.46: Chromatographic separation techniques
• ISO/IEC 17025:2017 for accredited analytical laboratories
• ICH Q3A/B: Impurities in new drug substances/products

Typical usage ratio

• Reference standard solutions prepared at 100–1000 μg/mL; aliquot dosages vary according to method validation and calibration curve requirements in analytical labs.

Downstream process integration

• Material precisely weighed, dissolved and standardized for calibration solution preparation; stored under controlled conditions before integration into pharmaceutical release and stability assay workflows.

Final product types

• Pharmaceutical impurity reference standards
• Certified analytical controls for GMP/GLP lab assays
• Calibration vials for HPLC, UPLC, and LC-MS laboratories